Eli Lilly infection patient Immunic Eli Lilly

FDA approves 1st drug treatment for alopecia hair loss

Reading now: 308
www.fox29.com

Before and after images for participants who received 36 weeks of treatment for alopecia areata with baricitinib. (Credit: Provided image / Yale School of Medicine) A treatment for those with severe alopecia areata, an immune disorder that often results in hair loss, has been approved by the U.S.

Food and Drug Administration for the first time.Alopecia areata, commonly referred to as just alopecia, is an autoimmune disorder in which the body attacks its own hair follicles, causing hair to fall out and often in clumps.

The drug, called Olumiant (baricitinib), is the first FDA approval of a full-body drug for the condition, according to an agency statement.The drug was originally approved in 2018 as a treatment for those suffering from moderately to severely active rheumatoid arthritis and was developed by the pharmaceutical company Eli Lilly.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Action against officials who fail to implement COPE decisions - newsfirst.lk - Sri Lanka
newsfirst.lk
44%
839
Action against officials who fail to implement COPE decisions
COLOMBO (News 1st); The Chairman of the Committee on Public Enterprises (COPE) and Member of Parliament (Prof) Charitha Herath said that the Parliament will focus on taking special measures against officials who do not implement the recommendations and decisions made by COPE.He mentioned this at a special meeting of the Committee on Public Enterprises which was held in Parliament on Monday (04).The meeting was held especially with the participation of the members of the committee and the views of its members on 3 main issues were obtained.Accordingly, the review of the progress made pertaining to COPE investigations conducted during the period from February 23rd, 2022 to date was considered at the meeting.Accordingly, the Chairman of COPE stated that the investigations carried out during this period have been complied into a report and copies of the report have been given to the members of the committee.He further mentioned that the decisions related to several institutions including SriLankan Airlines, Central Bank of Sri Lanka, State Timber Corporation, People’s Bank, Development Lotteries Board, Building Materials Corporation, Litro Gas Lanka Limited and Litro Gas Terminal Lanka (Private) Limited were included in the report.The chairman of the committee further pointed out that certain reports related to certain decisions given by the committee have not yet been given to the committee by these institutions.The Members of Parliament who were present, pointed out that strict action should be taken against the officials who do not implement these decisions. They pointed out that the Parliament and the committee should intervene further regarding the matter.
DMCA